Shares of Agile Therapeutics, Inc. (AGRX) are surging over 70% on Tuesday morning despite no stock-related new release from the company.
AGRX is currently trading at $2.1608, up $0.8908 or 70.1417%, on the Nasdaq. The stock opened its trading at $1.67 after closing Monday's trading at $1.27.
Agile Therapeutics, a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.